After-Hours Stock Movers: Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...
网页链接After-Hours Stock Movers: Cortexyme, Inc. (Nasdaq: CRTX) 70% LOWER; reported top-line results from its Phase 2/3 GAIN Trial, a double-blind, placebo-controlled study evaluating the efficacy of ...
网页链接
精彩评论